XML 45 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions
12 Months Ended
Jun. 30, 2020
Related Party Transactions  
Related Party Transactions

Note 17.  Related Party Transactions

The Company had sales of $3.0 million, $3.8 million and $3.9 million during the fiscal years ended June 30, 2020, 2019 and 2018, respectively, to a generic distributor, Auburn Pharmaceutical Company (“Auburn ”), which is a member of the Premier Buying Group.  Jeffrey Farber, a current board member, is the owner of Auburn.  Accounts receivable includes amounts due from Auburn of $0.7 million and $1.2 million at June 30, 2020 and 2019, respectively.

The Company also had net sales of $2.6 million, $2.4 million, and $1.9 million during the fiscal years ended June 30, 2020, 2019 and 2018, respectively, to a generic distributor, KeySource Medical (“KeySource), which is a member of the OptiSource Buying Group.  Albert Paonessa, a board member until the date of the Company’s 2020 Annual meeting of Stockholders, was appointed the CEO of KeySource in May 2017.  Accounts receivable includes amounts due from KeySource of $0.6 million and $0.7 million as of June 30, 2020 and 2019.